Invention Grant
US07994170B2 1,3-dihydro-imidazo[4,5-C]quinolin-2-ones as lipid kinase inhibitors
有权
1,3-二氢 - 咪唑并[4,5-C]喹啉-2-酮作为脂质激酶抑制剂
![1,3-dihydro-imidazo[4,5-C]quinolin-2-ones as lipid kinase inhibitors](/docs/US/2011-08-09/US07994170B2/abs.jpg.600x600.jpg)
- Patent Title: 1,3-dihydro-imidazo[4,5-C]quinolin-2-ones as lipid kinase inhibitors
- Patent Title (中): 1,3-二氢 - 咪唑并[4,5-C]喹啉-2-酮作为脂质激酶抑制剂
-
Application No.: US12577268Application Date: 2009-10-12
-
Publication No.: US07994170B2Publication Date: 2011-08-09
- Inventor: Carlos Garcia-Echeverria , Frédéric Stauffer , Pascal Furet
- Applicant: Carlos Garcia-Echeverria , Frédéric Stauffer , Pascal Furet
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agent Sandra Rueck
- Priority: GB0510390.8 20050520
- Main IPC: C07D471/04
- IPC: C07D471/04 ; A61K31/4188
![1,3-dihydro-imidazo[4,5-C]quinolin-2-ones as lipid kinase inhibitors](/abs-image/US/2011/08/09/US07994170B2/abs.jpg.150x150.jpg)
Abstract:
The invention relates to novel organic compounds of formula (I) processes for the preparation thereof, the application thereof in a process for the treatment of the human or animal body, the use thereof—alone or in combination with one or more other pharmaceutically active compounds—for the treatment of an inflammatory or obstructive airway disease, such as asthma, disorders commonly occurring in connection with transplantation, or a proliferative disease, such as a tumor disease.
Public/Granted literature
- US20100056558A1 1,3-DIHYDRO-IMIDAZO[4,5-C]QUINOLIN-2-ONES AS LIPID KINASE INHIBITORS Public/Granted day:2010-03-04
Information query
